November 16, 2023 - World Pancreatic Cancer Day
Join communities and organizations around the world as we unite to shine a light on pancreatic cancer
Check back in with us in April 2024 about our upcoming events:
- Continuing Medical Education Conference on Pancreatic Cancer
- PanCAN PurpleStride 2024
In the News
Biological Dynamics and the BCCPC Collaborate on Early-Stage Pancreatic Cancer Detection Study
To address the need for earlier detection of pancreatic cancer, the BCCPC is collaborating with Biological Dynamics, Inc. and providing important sample cohorts to study its ExoVita™ Pancreas assay for early disease diagnostics.
Using their proprietary ExoVerita instrument to isolate extracellular vesicles from standard blood samples, the ExoVita Pancreas assay measures specific extracellular vesicle protein biomarkers. Capable of detecting Stage 1 and 2 pancreatic cancer with high sensitivity, ExoVita Pancreas is a promising diagnostic test. To test the assay's utility, Biological Dynamics initiated the ExoLuminate registry study (NCT05625529)— a clinical trial enrolling patients at high-risk for PDAC to demonstrate effectiveness of early-stage pancreatic cancer detection. BCCPC is a participating site for this exciting study.